Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Validation of Algorithms Used to Identify Red Blood Cell Transfusion Related Admissions in Veteran Patients with End Stage Renal Disease.

Peters CB, Hansen JL, Halwani A, Cho ME, Leng J, Huynh T, Burningham Z, Caloyeras J, Matsuda T, Sauer BC.

EGEMS (Wash DC). 2019 Jul 3;7(1):23. doi: 10.5334/egems.257.

PMID:
31304183
2.

Learning to detect and understand drug discontinuation events from clinical narratives.

Liu F, Pradhan R, Druhl E, Freund E, Liu W, Sauer BC, Cunningham F, Gordon AJ, Peters CB, Yu H.

J Am Med Inform Assoc. 2019 Apr 29. pii: ocz048. doi: 10.1093/jamia/ocz048. [Epub ahead of print]

PMID:
31034028
3.

Identification of axial spondyloarthritis patients in a large dataset: the development and validation of novel methods.

Walsh JA, Pei S, Penmetsa G, Hansen JL, Cannon GW, Clegg DO, Sauer BC.

J Rheumatol. 2019 Mar 15. pii: jrheum.181005. doi: 10.3899/jrheum.181005. [Epub ahead of print]

PMID:
30877217
4.

Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis.

McCulley CB, Barton JL, Cannon GW, Sauer BC, Teng CC, George MD, Caplan L, England BR, Mikuls TR, Baker JF.

Clin Exp Rheumatol. 2019 May-Jun;37(3):422-428. Epub 2018 Nov 7.

5.

Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry.

Stever JR, Cannon GW, Teng CC, Accortt NA, Collier DH, Sauer BC.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):552-560. Epub 2018 Nov 12.

PMID:
30418115
6.

Clinical and Economic Outcomes of Ranolazine Versus Conventional Antianginals Users Among Veterans With Chronic Stable Angina Pectoris.

Bress AP, Dodson JA, King JB, Sauer BC, Reese T, Crook J, Radwanski P, Knippenberg K, Greene T, Nelson RE, Munger MA, Weintraub WS, LaFleur J.

Am J Cardiol. 2018 Dec 1;122(11):1809-1816. doi: 10.1016/j.amjcard.2018.08.027. Epub 2018 Sep 8.

PMID:
30292334
7.

Chronic lung disease in U.S. Veterans with rheumatoid arthritis and the impact on survival.

England BR, Sayles H, Michaud K, Thiele GM, Poole JA, Caplan L, Sauer BC, Cannon GW, Reimold A, Kerr GS, Baker JF, Mikuls TR.

Clin Rheumatol. 2018 Nov;37(11):2907-2915. doi: 10.1007/s10067-018-4314-9. Epub 2018 Oct 2.

PMID:
30280369
8.

Biologic and Glucocorticoid Use after Methotrexate Initiation in Patients with Rheumatoid Arthritis.

George MD, Sauer BC, Teng CC, Cannon GW, England BR, Kerr GS, Mikuls TR, Baker JF.

J Rheumatol. 2019 Apr;46(4):343-350. doi: 10.3899/jrheum.180178. Epub 2018 Oct 1.

PMID:
30275262
9.

Low Persistence Rates in Rheumatoid Arthritis Patients Treated with Triple Therapy are Attributed to Adverse Drug Events Associated with Sulfasalazine.

Erhardt DP, Cannon GW, Teng CC, Mikuls TR, Curtis JR, Sauer BC.

Arthritis Care Res (Hoboken). 2018 Sep 17. doi: 10.1002/acr.23759. [Epub ahead of print]

PMID:
30221485
10.

Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods.

Walsh JA, Pei S, Penmetsa GK, Leng J, Cannon GW, Clegg DO, Sauer BC.

BMC Musculoskelet Disord. 2018 Sep 5;19(1):317. doi: 10.1186/s12891-018-2211-7.

11.

Predicting Psychiatric Hospitalizations among Elderly Veterans with a History of Mental Health Disease.

Burningham Z, Leng J, Peters CB, Huynh T, Halwani A, Rupper R, Hicken B, Sauer BC.

EGEMS (Wash DC). 2018 May 17;6(1):7. doi: 10.5334/egems.207.

12.

Obesity, Weight Loss, and Progression of Disability in Rheumatoid Arthritis.

Baker JF, England BR, Mikuls TR, Sayles H, Cannon GW, Sauer BC, George MD, Caplan L, Michaud K.

Arthritis Care Res (Hoboken). 2018 Dec;70(12):1740-1747. doi: 10.1002/acr.23579.

PMID:
29707921
13.

Development and Validation of a Natural Language Processing Tool to Identify Patients Treated for Pneumonia across VA Emergency Departments.

Jones BE, South BR, Shao Y, Lu CC, Leng J, Sauer BC, Gundlapalli AV, Samore MH, Zeng Q.

Appl Clin Inform. 2018 Jan;9(1):122-128. doi: 10.1055/s-0038-1626725. Epub 2018 Feb 21.

14.

Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance.

Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC.

J Rheumatol. 2018 Mar;45(3):430-436. doi: 10.3899/jrheum.170554. Epub 2017 Nov 15.

PMID:
29142040
15.

Variation in Empiric Coverage Versus Detection of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa in Hospitalizations for Community-Onset Pneumonia Across 128 US Veterans Affairs Medical Centers.

Jones BE, Brown KA, Jones MM, Huttner BD, Greene T, Sauer BC, Madaras-Kelly K, Rubin MA, Bidwell Goetz M, Samore MH.

Infect Control Hosp Epidemiol. 2017 Aug;38(8):937-944. doi: 10.1017/ice.2017.98. Epub 2017 Jun 21.

16.

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity.

Sauer BC, Teng CC, Accortt NA, Burningham Z, Collier D, Trivedi M, Cannon GW.

Arthritis Res Ther. 2017 May 8;19(1):86. doi: 10.1186/s13075-017-1294-0.

17.

Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection.

Burningham Z, He T, Teng CC, Zhou X, Nebeker J, Sauer BC.

Drug Saf. 2017 Sep;40(9):789-798. doi: 10.1007/s40264-017-0540-3.

PMID:
28474287
18.

Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

England BR, Baker JF, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Mikuls TR.

Arthritis Care Res (Hoboken). 2018 Jan;70(1):11-18. doi: 10.1002/acr.23258. Epub 2017 Dec 6.

19.

Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.

George MD, Giles JT, Katz PP, England BR, Mikuls TR, Michaud K, Ogdie-Beatty AR, Ibrahim S, Cannon GW, Caplan L, Sauer BC, Baker JF.

Arthritis Care Res (Hoboken). 2017 Dec;69(12):1789-1798. doi: 10.1002/acr.23229. Epub 2017 Nov 6.

20.

Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans.

Walsh JA, Shao Y, Leng J, He T, Teng CC, Redd D, Treitler Zeng Q, Burningham Z, Clegg DO, Sauer BC.

Arthritis Care Res (Hoboken). 2017 Sep;69(9):1414-1420. doi: 10.1002/acr.23140. Epub 2017 Aug 8.

21.

The use of natural language processing on narrative medication schedules to compute average weekly dose.

Lu CC, Leng J, Cannon GW, Zhou X, Egger M, South B, Burningham Z, Zeng Q, Sauer BC.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1414-1424. doi: 10.1002/pds.4086. Epub 2016 Sep 16.

PMID:
27633139
22.

Performance of a Natural Language Processing (NLP) Tool to Extract Pulmonary Function Test (PFT) Reports from Structured and Semistructured Veteran Affairs (VA) Data.

Sauer BC, Jones BE, Globe G, Leng J, Lu CC, He T, Teng CC, Sullivan P, Zeng Q.

EGEMS (Wash DC). 2016 Jun 1;4(1):1217. doi: 10.13063/2327-9214.1217. eCollection 2016.

23.

Clinical Outcomes and Biologic Costs of Switching Between Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis.

Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Joseph GJ, Harrison DJ, Sauer BC.

Adv Ther. 2016 Aug;33(8):1347-59. doi: 10.1007/s12325-016-0371-0. Epub 2016 Jun 28.

24.

Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.

Sauer BC, Teng CC, Tang D, Leng J, Curtis JR, Mikuls TR, Harrison DJ, Cannon GW.

Arthritis Care Res (Hoboken). 2017 Mar;69(3):313-322. doi: 10.1002/acr.22944.

25.

Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses.

Hernán MA, Sauer BC, Hernández-Díaz S, Platt R, Shrier I.

J Clin Epidemiol. 2016 Nov;79:70-75. doi: 10.1016/j.jclinepi.2016.04.014. Epub 2016 May 27. Review.

26.

Evidence generation from healthcare databases: recommendations for managing change.

Bourke A, Bate A, Sauer BC, Brown JS, Hall GC.

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):749-54. doi: 10.1002/pds.4004. Epub 2016 May 17. Review.

PMID:
27183900
27.

Changes in Body Mass Related to the Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis.

Baker JF, Sauer BC, Cannon GW, Teng CC, Michaud K, Ibrahim S, Jorgenson E, Davis L, Caplan L, Cannella A, Mikuls TR.

Arthritis Rheumatol. 2016 Aug;68(8):1818-27. doi: 10.1002/art.39647.

28.

Development and evaluation of a record linkage protocol for Utah's Controlled Substance Database.

Mohanty AF, Crook J, Porucznik CA, Johnson EM, Rolfs RT, Sauer BC.

Health Informatics J. 2017 Mar;23(1):35-43. doi: 10.1177/1460458215618520. Epub 2016 Jul 25.

PMID:
26701972
29.

Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis.

Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW.

J Med Econ. 2016;19(1):34-43. doi: 10.3111/13696998.2015.1086774. Epub 2015 Sep 30.

PMID:
26337538
30.

Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.

Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A.

Drug Saf. 2015 Aug;38(8):767-8. doi: 10.1007/s40264-015-0322-8. No abstract available.

PMID:
26136091
31.

Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis.

England BR, Sayles H, Michaud K, Caplan L, Davis LA, Cannon GW, Sauer BC, Solow EB, Reimold AM, Kerr GS, Schwab P, Baker JF, Mikuls TR.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):36-45. doi: 10.1002/acr.22642.

32.

A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.

Xu Y, Zhou X, Suehs BT, Hartzema AG, Kahn MG, Moride Y, Sauer BC, Liu Q, Moll K, Pasquale MK, Nair VP, Bate A.

Drug Saf. 2015 Aug;38(8):749-65. doi: 10.1007/s40264-015-0297-5. Erratum in: Drug Saf. 2015 Aug;38(8):767-8.

PMID:
26055920
33.

Mortality associated with lithium and valproate treatment of US Veterans Health Administration patients with mental disorders.

Smith EG, Austin KL, Kim HM, Eisen SV, Kilbourne AM, Miller DR, Zivin K, Hannemann C, Sauer BC, Valenstein M.

Br J Psychiatry. 2015 Jul;207(1):55-63. doi: 10.1192/bjp.bp.113.138685. Epub 2015 May 7.

PMID:
25953891
34.

Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study.

Smith EG, Austin KL, Kim HM, Miller DR, Eisen SV, Christiansen CL, Kilbourne AM, Sauer BC, McCarthy JF, Valenstein M.

BMC Psychiatry. 2014 Dec 17;14:357. doi: 10.1186/s12888-014-0357-x.

35.

Persistence and dose escalation of tumor necrosis factor inhibitors in US veterans with rheumatoid arthritis.

Cannon GW, DuVall SL, Haroldsen CL, Caplan L, Curtis JR, Michaud K, Mikuls TR, Reimold A, Collier DH, Harrison DJ, Joseph GJ, Sauer BC.

J Rheumatol. 2014 Oct;41(10):1935-43. doi: 10.3899/jrheum.140164. Epub 2014 Aug 15.

36.

Propofol is associated with favorable outcomes compared with benzodiazepines in ventilated intensive care unit patients.

Lonardo NW, Mone MC, Nirula R, Kimball EJ, Ludwig K, Zhou X, Sauer BC, Nechodom K, Teng C, Barton RG.

Am J Respir Crit Care Med. 2014 Jun 1;189(11):1383-94. doi: 10.1164/rccm.201312-2291OC. Erratum in: Am J Respir Crit Care Med. 2014 Jun 1;189(11):e70.

PMID:
24720509
37.

Documentation of delirium in the VA electronic health record.

Hope C, Estrada N, Weir C, Teng CC, Damal K, Sauer BC.

BMC Res Notes. 2014 Apr 3;7:208. doi: 10.1186/1756-0500-7-208.

38.

Specialty of prescribers associated with prescription opioid fatalities in Utah, 2002-2010.

Porucznik CA, Johnson EM, Rolfs RT, Sauer BC.

Pain Med. 2014 Jan;15(1):73-8. doi: 10.1111/pme.12247. Epub 2013 Oct 9.

PMID:
24118974
39.

A review of covariate selection for non-experimental comparative effectiveness research.

Sauer BC, Brookhart MA, Roy J, VanderWeele T.

Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1139-45. doi: 10.1002/pds.3506. Epub 2013 Sep 5. Review.

40.

Opioid prescribing knowledge and practices: provider survey following promulgation of guidelines-Utah, 2011.

Porucznik CA, Johnson EM, Rolfs RT, Sauer BC.

J Opioid Manag. 2013 May-Jun;9(3):217-24. doi: 10.5055/jom.2013.0162.

PMID:
23771571
41.

Medical home characteristics and asthma control: a prospective, observational cohort study protocol.

Sills MR, Kwan BM, Yawn BP, Sauer BC, Fairclough DL, Federico MJ, Juarez-Colunga E, Schilling LM.

EGEMS (Wash DC). 2013 Dec 18;1(3):1032. doi: 10.13063/2327-9214.1032. eCollection 2013.

42.

Application of system-level root cause analysis for drug quality and safety problems: a case study.

Sauer BC, Hepler CD.

Res Social Adm Pharm. 2013 Jan-Feb;9(1):49-59. doi: 10.1016/j.sapharm.2012.02.005. Epub 2012 May 2.

PMID:
22554397
43.

Information extraction from narrative data.

Hope CJ, Garvin JH, Sauer BC.

Am J Health Syst Pharm. 2012 Mar 15;69(6):455, 460-1. doi: 10.2146/ajhp110135. No abstract available.

PMID:
22382475
44.

Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture.

Nelson RE, Nebeker JR, Sauer BC, LaFleur J.

Bone. 2012 Apr;50(4):983-8. doi: 10.1016/j.bone.2011.11.014. Epub 2012 Jan 18.

PMID:
22266156
45.

Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice.

Cannon GW, Mikuls TR, Hayden CL, Ying J, Curtis JR, Reimold AM, Caplan L, Kerr GS, Richards JS, Johnson DS, Sauer BC.

Arthritis Care Res (Hoboken). 2011 Dec;63(12):1680-90. doi: 10.1002/acr.20629.

46.

Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension.

LaFleur J, Nelson RE, Sauer BC, Nebeker JR.

Heart. 2011 Nov;97(22):1862-9. doi: 10.1136/hrt.2011.223289. Epub 2011 May 17.

PMID:
21586421
47.

An agent-based model for evaluating surveillance methods for catheter-related bloodstream infection.

Rubin MA, Mayer J, Greene T, Sauer BC, Hota B, Trick W, Jernigan JA, Samore MH.

AMIA Annu Symp Proc. 2008 Nov 6:631-5.

48.

Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data.

Nebeker JR, Yarnold PR, Soltysik RC, Sauer BC, Sims SA, Samore MH, Rupper RW, Swanson KM, Savitz LA, Shinogle J, Xu W.

Med Care. 2007 Oct;45(10 Supl 2):S81-8.

PMID:
17909388
49.

Out-of-pocket pharmacy expenditures for veterans under medicare part D.

Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M.

Med Care. 2007 Oct;45(10 Supl 2):S77-80.

PMID:
17909387
50.

Computerized indicators of potential drug-related emergency department and hospital admissions.

Sauer BC, Hepler CD, Cherney B, Williamson J.

Am J Manag Care. 2007 Jan;13(1):29-35.

Supplemental Content

Loading ...
Support Center